SARS-COV-2 infections in inborn errors of immunity : A single center study
Copyright © 2022 Cousins, DeFelice, Jeong, Feng, Lee, Rotella, Sanchez, Jaber, Agarwal, Ho and Cunningham-Rundles..
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). One of the main topics of conversation in these past months in the world of immunology has been the issue of how patients with immune defects will fare if they contract this infection. To date there has been limited data on larger cohorts of patients with Inborn Errors of Immunity (IEI) diagnosed with COVID-19. Here, we review the data of COVID-19 infections in a single center cohort of 113 patients from the Mount Sinai Immunodeficiency program, who had 132 infections between January 2020 and June 2022. This included 56 males and 57 females, age range 2 - 84 (median 42). The mortality rate was 3%. Comparison between admitted patients revealed a significantly increased risk of hospitalization amongst the unvaccinated patients, 4% vaccinated vs 40% unvaccinated; odds ratio 15.0 (95% CI 4.2 - 53.4; p <0.00001). Additionally, COVID anti-spike antibody levels, determined in 36 of these patients post vaccination and before infection, were highly variable.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Frontiers in immunology - 13(2022) vom: 30., Seite 1035571 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cousins, Kimberley [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 15.12.2022 Date Revised 16.06.2023 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.3389/fimmu.2022.1035571 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM349914931 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM349914931 | ||
| 003 | DE-627 | ||
| 005 | 20231226205654.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fimmu.2022.1035571 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1166.xml |
| 035 | |a (DE-627)NLM349914931 | ||
| 035 | |a (NLM)36479106 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cousins, Kimberley |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SARS-COV-2 infections in inborn errors of immunity |b A single center study |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.12.2022 | ||
| 500 | |a Date Revised 16.06.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Cousins, DeFelice, Jeong, Feng, Lee, Rotella, Sanchez, Jaber, Agarwal, Ho and Cunningham-Rundles. | ||
| 520 | |a Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). One of the main topics of conversation in these past months in the world of immunology has been the issue of how patients with immune defects will fare if they contract this infection. To date there has been limited data on larger cohorts of patients with Inborn Errors of Immunity (IEI) diagnosed with COVID-19. Here, we review the data of COVID-19 infections in a single center cohort of 113 patients from the Mount Sinai Immunodeficiency program, who had 132 infections between January 2020 and June 2022. This included 56 males and 57 females, age range 2 - 84 (median 42). The mortality rate was 3%. Comparison between admitted patients revealed a significantly increased risk of hospitalization amongst the unvaccinated patients, 4% vaccinated vs 40% unvaccinated; odds ratio 15.0 (95% CI 4.2 - 53.4; p <0.00001). Additionally, COVID anti-spike antibody levels, determined in 36 of these patients post vaccination and before infection, were highly variable | ||
| 650 | 4 | |a Review | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a X-linked agammaglobulinemia (XLA) | |
| 650 | 4 | |a common variable immunodeficiency (CVID) | |
| 650 | 4 | |a coronavirus disease 2019 (COVID-19) | |
| 650 | 4 | |a covid vaccination | |
| 650 | 4 | |a inborn errors of immunity (IEI) | |
| 650 | 4 | |a monoclonal therapy | |
| 650 | 4 | |a primary immunodeficiency (PID) | |
| 650 | 4 | |a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | |
| 700 | 1 | |a DeFelice, Nicholas |e verfasserin |4 aut | |
| 700 | 1 | |a Jeong, Stephanie |e verfasserin |4 aut | |
| 700 | 1 | |a Feng, Jin |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Ashley Sang Eun |e verfasserin |4 aut | |
| 700 | 1 | |a Rotella, Karina |e verfasserin |4 aut | |
| 700 | 1 | |a Sanchez, David |e verfasserin |4 aut | |
| 700 | 1 | |a Jaber, Faris |e verfasserin |4 aut | |
| 700 | 1 | |a Agarwal, Shradha |e verfasserin |4 aut | |
| 700 | 1 | |a Ho, Hsi-En |e verfasserin |4 aut | |
| 700 | 1 | |a Cunningham-Rundles, Charlotte |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in immunology |d 2010 |g 13(2022) vom: 30., Seite 1035571 |w (DE-627)NLM215811453 |x 1664-3224 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2022 |g day:30 |g pages:1035571 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fimmu.2022.1035571 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2022 |b 30 |h 1035571 | ||